111 related articles for article (PubMed ID: 3893490)
21. Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure.
Packer M; Medina N; Yushak M
J Am Coll Cardiol; 1984 Apr; 3(4):1035-43. PubMed ID: 6323565
[TBL] [Abstract][Full Text] [Related]
22. [Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
Allal J; Pornin M; Rossi F; Poupet JY; Bordage JP; Barraine R
Arch Mal Coeur Vaiss; 1984 Apr; 77(4):458-67. PubMed ID: 6426432
[TBL] [Abstract][Full Text] [Related]
23. Immediate effects of captopril in acute left ventricular failure secondary to myocardial infarction.
Brivet F; Delfraissy JF; Giudicelli JF; Richer C; Legrand A; Dormont J
Eur J Clin Invest; 1981 Oct; 11(5):369-73. PubMed ID: 6800808
[TBL] [Abstract][Full Text] [Related]
24. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Sharpe DN; Coxon R
Aust N Z J Med; 1982 Oct; 12(5):483-8. PubMed ID: 6758746
[TBL] [Abstract][Full Text] [Related]
25. Improvement of chronic congestive heart-failure by oral captopril.
Turini GA; Brunner HR; Gribic M; Waeber B; Gavras H
Lancet; 1979 Jun; 1(8128):1213-5. PubMed ID: 87679
[TBL] [Abstract][Full Text] [Related]
26. Haemodynamic effects of captopril in acute left ventricular failure complicating myocardial infarction.
McAlpine HM; Morton JJ; Leckie B; Dargie HJ
J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S25-30. PubMed ID: 2441196
[TBL] [Abstract][Full Text] [Related]
27. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.
Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH
N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810
[TBL] [Abstract][Full Text] [Related]
28. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
Schofer J; Hobuss M; Aschenberg W; Tews A
Eur Heart J; 1990 Aug; 11(8):712-21. PubMed ID: 1975780
[TBL] [Abstract][Full Text] [Related]
29. Haemodynamic, hormonal, and electrolyte responses to withdrawal of long-term captopril treatment for heart failure.
Maslowski AH; Nicholls MG; Ikram H; Espiner EA; Turner JG
Lancet; 1981 Oct; 2(8253):959-61. PubMed ID: 6117729
[TBL] [Abstract][Full Text] [Related]
30. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
[TBL] [Abstract][Full Text] [Related]
31. The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure.
Flapan AD; Davies E; Williams BC; Shaw TR; Edwards CR
Eur Heart J; 1992 Jul; 13(7):971-5. PubMed ID: 1644090
[TBL] [Abstract][Full Text] [Related]
32. Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.
Dahlström U; Karlberg BE
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):231S-235S. PubMed ID: 6753905
[TBL] [Abstract][Full Text] [Related]
33. Captopril in congestive heart failure resistant to other vasodilators.
Fouad FM; El-Tobgi S; Tarazi RC; Bravo EL; Hart NJ; Shirey EK; Lim J
Eur Heart J; 1984 Jan; 5(1):47-54. PubMed ID: 6368232
[TBL] [Abstract][Full Text] [Related]
34. Captopril kinetics in chronic congestive heart failure.
Cody RJ; Schaer GL; Covit AB; Pondolfino K; Williams G
Clin Pharmacol Ther; 1982 Dec; 32(6):721-6. PubMed ID: 6754211
[TBL] [Abstract][Full Text] [Related]
35. Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.
Bayliss J; Norell MS; Canepa-Anson R; Reid C; Poole-Wilson P; Sutton G
Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1861-5. PubMed ID: 3924285
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.
Fujita T; Ando K; Noda H; Sato Y; Yamashita N; Yamashita K
Am J Med; 1982 Sep; 73(3):341-7. PubMed ID: 6751080
[TBL] [Abstract][Full Text] [Related]
37. Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment.
Sharpe DN; Douglas JE; Coxon RJ; Long B
Lancet; 1980 Nov; 2(8205):1154-7. PubMed ID: 6107767
[TBL] [Abstract][Full Text] [Related]
38. Contrasting patterns of arterial and venous dilatation after intravenous captopril in patients with chronic cardiac failure and their relationship to plasma angiotensin II concentrations.
Flapan AD; Shaw TR; Edwards CR; Davies E; Williams BC
Am Heart J; 1992 Nov; 124(5):1270-6. PubMed ID: 1442495
[TBL] [Abstract][Full Text] [Related]
39. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
Townend JN; Doran J; Lote CJ; Davies MK
Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
[TBL] [Abstract][Full Text] [Related]
40. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
